ArticleCureus2025
Impact of Surgical Treatment on the Quality of Life in Patients With Chronic Otitis Media With Cholesteatoma: A Prospective Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Chronic otitis media with cholesteatoma (COMC) is a progressive and potentially destructive middle ear disease, with surgery as the treatment of choice. Its auditory, emotional, and social consequences significantly affect patients' quality of life. The Chronic Otitis Media Questionnaire-12, Mexican version (COMQ-12-Mx), allows a validated assessment of this impact in the Mexican population. Objective The main objective of this study is to evaluate the effect of surgical treatment on quality of life and auditory function in patients with COMC, using the COMQ-12-Mx. Material and methods A prospective cohort study was conducted at the University Center of Otolaryngology and Head and Neck Surgery, "Dr. José Eleuterio González" University Hospital, Monterrey, Mexico, from May to October 2025. Twenty-five adults with clinically and radiologically confirmed COMC were included. The COMQ-12-Mx and audiometric tests were applied before and three months after surgery. Results Twenty-five affected ears were analyzed (median age 47 years; 56% female). The most frequent comorbidities were type 2 diabetes (32%), bilateral chronic otitis media (28%), and hypertension (16%). Main symptoms included tinnitus (68%), otalgia (64%), and otorrhea (64%). The attic-antral region was most commonly involved (68%). Simple mastoidectomy (76%) and type III tympanoplasty (78.6%) were the predominant techniques. Postoperative complications occurred in 24%, mainly graft perforation (16%). The pure-tone average (PTA) showed a trend toward improvement (48 dB preoperative vs 42 dB postoperative; p = 0.059). Total COMQ-12-Mx scores significantly decreased (29 vs 21; p < 0.001), with improvement across all subdomains and a large effect size (r = 0.87). Both canal wall up (CWU) and endoscopic techniques improved global scores, while only CWU showed significant PTA improvement (p = 0.041). Conclusions Surgery for COMC was associated with within-group improvement in quality of life, particularly in symptoms and emotional impact. The COMQ-12-Mx adequately detected postoperative changes and served as a reliable tool to assess clinical and functional outcomes after surgical treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.